TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $319,149 | -97.2% | 35,699 | -95.1% | 0.00% | -97.6% |
| Q2 2023 | $11,272,120 | +1115.6% | 733,862 | +1679.9% | 0.04% | +192.9% |
| Q1 2023 | $927,285 | -91.3% | 41,231 | -91.9% | 0.01% | -92.8% |
| Q4 2022 | $10,663,955 | +27.9% | 507,083 | +49.8% | 0.19% | +22.0% |
| Q3 2022 | $8,339,000 | +65.6% | 338,424 | +62.8% | 0.16% | +14.4% |
| Q2 2022 | $5,037,000 | +17.4% | 207,895 | +24.8% | 0.14% | +20.9% |
| Q1 2022 | $4,291,000 | +220.7% | 166,520 | +286.4% | 0.12% | +173.8% |
| Q4 2021 | $1,338,000 | +303.0% | 43,095 | +89.2% | 0.04% | +281.8% |
| Q2 2021 | $332,000 | +50.2% | 22,778 | +157.5% | 0.01% | -15.4% |
| Q1 2021 | $221,000 | – | 8,847 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |